4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-045099
President and CEO sold 20,000 shares at $9.04 ($180,800)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin President and CEO | 2023-08-07 | Sale | −20,000 | $9.04 | $180,800 | 7,613,467 | D |
| Open-market sales · 20,000 sh · avg $9.04 · $180,800 | |||||||
Loading xslF345X05/doc4.xml…